Zur Rose Group AG
A European e-commerce pharmacy providing an online platform for medicines and health.
ROSE | SW
Overview
Corporate Details
- ISIN(s):
- CH0042615283 (+1 more)
- LEI:
- 50670038OH136R5Z4663
- Country:
- Switzerland
- Address:
- Walzmühlestrasse 49, 8500 Frauenfeld
- Sector:
- Wholesale and retail trade
Description
DocMorris AG, formerly Zur Rose Group AG, is a leading European e-commerce pharmacy. The company provides an online platform for medicines and develops digital health services. Its core strategy involves creating a comprehensive digital health ecosystem that connects patients, doctors, pharmacies, and health insurers on a single platform. The company's vision is to enable individuals to manage their health with a single click, offering integrated care and treatment solutions. Originally founded as a pharmacy wholesaler, it has evolved to focus on the digitalization of healthcare services.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-13 17:41 |
DocMorris announces the results of the tender offer for its Outstanding Convert…
|
English | 14.0 KB | ||
| 2025-11-13 01:00 |
DocMorris announces the results of the tender offer for its Outstanding Convert…
|
English | 12.8 KB | ||
| 2025-11-13 01:00 |
DocMorris gibt die Ergebnisse des Rückkaufangebots für die ausstehenden Wandela…
|
German | 14.5 KB | ||
| 2025-11-06 07:00 |
DocMorris announces the start of the tender offer period for its Outstanding Co…
|
English | 14.1 KB | ||
| 2025-11-06 01:00 |
DocMorris announces the start of the tender offer period for its Outstanding Co…
|
English | 12.9 KB | ||
| 2025-11-06 01:00 |
DocMorris kündigt Beginn der Rückkaufangebotsfrist für die ausstehenden Wandel…
|
German | 15.0 KB | ||
| 2025-10-22 07:00 |
DocMorris successfully completes the placement of CHF 49.6 million Convertible …
|
English | 20.1 KB | ||
| 2025-10-22 02:00 |
DocMorris successfully completes the placement of CHF 49.6 million Convertible …
|
English | 19.0 KB | ||
| 2025-10-22 02:00 |
DocMorris schliesst Platzierung einer CHF 49.6 Mio. Wandelanleihe mit Fälligkei…
|
German | 20.2 KB | ||
| 2025-10-21 17:53 |
DocMorris launches approx. CHF 45 million Convertible Bonds due 2028 to fund ea…
|
English | 21.1 KB | ||
| 2025-10-21 02:00 |
DocMorris launches approx. CHF 45 million Convertible Bonds due 2028 to fund ea…
|
English | 20.0 KB | ||
| 2025-10-21 02:00 |
DocMorris lanciert Wandelanleihe von etwa CHF 45 Millionen mit Fälligkeit 2028 …
|
German | 21.5 KB | ||
| 2025-10-16 07:00 |
DocMorris accelerates sequential Rx growth and increases non-Rx revenue
|
English | 24.2 KB | ||
| 2025-10-16 02:00 |
DocMorris accelerates sequential Rx growth and increases non-Rx revenue
|
English | 20.5 KB | ||
| 2025-10-16 02:00 |
DocMorris beschleunigt sequenzielles Rx-Wachstum und steigert Non-Rx-Umsätze
|
German | 21.3 KB |
Automate Your Workflow. Get a real-time feed of all Zur Rose Group AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Zur Rose Group AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Zur Rose Group AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-20 | N/A | Non-Executive member | Buy | None | 175,188.00 CHF |
| 2025-05-20 | N/A | Non-Executive member | Buy | None | 28,818.00 CHF |
| 2025-05-19 | N/A | Executive member | Buy | None | 34,500.00 CHF |
| 2025-05-19 | N/A | Non-Executive member | Buy | None | 14,040.00 CHF |
| 2025-05-19 | N/A | Executive member | Buy | None | 9,142.50 CHF |
| 2025-05-16 | N/A | Non-Executive member | Buy | None | 1,035,000.00 CHF |
| 2025-05-16 | N/A | Executive member | Buy | None | 46,400.00 CHF |
| 2025-05-16 | N/A | Executive member | Buy | None | 10,315.50 CHF |
| 2025-05-16 | N/A | Non-Executive member | Buy | None | 8,616.00 CHF |
| 2025-05-15 | N/A | Executive member | Buy | None | 678,770.25 CHF |
Peer Companies
